Literature DB >> 34284308

A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.

Kate E Valerio1, Katherine G Jonas2, Greg Perlman2, Evelyn J Bromet2, Roman Kotov2.   

Abstract

People diagnosed with schizophrenia and other psychoses demonstrate impaired neuropsychological performance. Their unaffected siblings exhibit mild impairments relative to unrelated controls, suggesting genetic and shared environmental risk for psychosis account for some portion of cognitive impairments observed in cases. However, most sibling studies were conducted early in illness course. Studying cases and unaffected siblings later in life is valuable because diagnostic misclassification is common early in illness, possibly leading to spurious conclusions. This study compared neuropsychological performance of individuals with psychotic disorders (schizophrenia and other psychoses), their unaffected siblings, and controls. Assessments were conducted 20 years after case enrollment in the Suffolk County Mental Health Project, when siblings and controls were added to the protocol. Results showed individuals with schizophrenia and other psychoses performed worse than their matched siblings across domains. Relative to controls, siblings of participants with schizophrenia showed mild deficits in executive function and processing speed, while no significant differences were observed between siblings of those with other psychoses and controls. These findings suggest pre- and post-onset factors impact cognitive deficits in psychosis, but pre-onset factors are more salient in schizophrenia. Additionally, schizophrenia and other psychoses exist on a neurodevelopmental continuum, with schizophrenia being a more severe manifestation.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Cohort studies; Neuropsychology; Psychotic disorders; Schizophrenia

Mesh:

Year:  2021        PMID: 34284308      PMCID: PMC8409437          DOI: 10.1016/j.psychres.2021.114111

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   11.225


  48 in total

1.  The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay.

Authors:  Philip D Harvey; Abraham Reichenberg; Christopher R Bowie; Thomas L Patterson; Robert K Heaton
Journal:  Biol Psychiatry       Date:  2010-03-03       Impact factor: 13.382

Review 2.  Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?

Authors:  Philip D Harvey; Jennifer B Rosenthal
Journal:  Schizophr Res       Date:  2017-05-12       Impact factor: 4.939

3.  Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Authors:  Richard S E Keefe; Robert M Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2006-04-19       Impact factor: 7.853

4.  Grey matter and cognitive deficits in young relatives of schizophrenia patients.

Authors:  Tejas S Bhojraj; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-03-31       Impact factor: 6.556

Review 5.  Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature.

Authors:  Vasilis P Bozikas; Christina Andreou
Journal:  Aust N Z J Psychiatry       Date:  2011-02       Impact factor: 5.744

6.  Cognitive functioning in siblings discordant for schizophrenia.

Authors:  C Hughes; V Kumari; M Das; E Zachariah; U Ettinger; A Sumich; T Sharma
Journal:  Acta Psychiatr Scand       Date:  2005-03       Impact factor: 6.392

Review 7.  Longitudinal studies of cognition in schizophrenia: meta-analysis.

Authors:  Andrei Szöke; Anca Trandafir; Marie-Estelle Dupont; Alexandre Méary; Franck Schürhoff; Marion Leboyer
Journal:  Br J Psychiatry       Date:  2008-04       Impact factor: 9.319

8.  Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence.

Authors:  Mario Fioravanti; Valentina Bianchi; Maria Elena Cinti
Journal:  BMC Psychiatry       Date:  2012-06-20       Impact factor: 3.630

9.  Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.

Authors:  Anja P Husa; Irina Rannikko; Jani Moilanen; Marianne Haapea; Graham K Murray; Jennifer Barnett; Peter B Jones; Matti Isohanni; Hannu Koponen; Jouko Miettunen; Erika Jääskeläinen
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

10.  Evidence of Common Genetic Overlap Between Schizophrenia and Cognition.

Authors:  Leon Hubbard; Katherine E Tansey; Dheeraj Rai; Peter Jones; Stephan Ripke; Kimberly D Chambert; Jennifer L Moran; Steven A McCarroll; David E J Linden; Michael J Owen; Michael C O'Donovan; James T R Walters; Stanley Zammit
Journal:  Schizophr Bull       Date:  2015-12-16       Impact factor: 9.306

View more
  1 in total

1.  Cognitive remediation in schizophrenia: What happens after 10 years?

Authors:  Mariachiara Buonocore; Marco Spangaro; Margherita Bechi; Stefania Trezzani; Rachele Terragni; Francesca Martini; Giulia Agostoni; Federica Cocchi; Federica Cuoco; Carmelo Guglielmino; Marta Bosia; Roberto Cavallaro
Journal:  Schizophr Res Cogn       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.